Evaluation of Pentraxin-3 as a Biomarker in Acute Coronary Syndrome
Rehab Shawkey Mohammed;
Abstract
The present study included 85 subjects; 65 patients with ACS, 10 healthy controls and 10 SA patients as a comparison group. ACS patients were divided into three groups; 22 patients with STEMI, 22 patients with NSTEMI and 21 patients with UA according to c
Other data
| Title | Evaluation of Pentraxin-3 as a Biomarker in Acute Coronary Syndrome | Authors | Rehab Shawkey Mohammed | Keywords | Evaluation of Pentraxin-3 as a Biomarker in Acute Coronary Syndrome | Issue Date | 2012 | Description | The present study included 85 subjects; 65 patients with ACS, 10 healthy controls and 10 SA patients as a comparison group. ACS patients were divided into three groups; 22 patients with STEMI, 22 patients with NSTEMI and 21 patients with UA according to c |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| 113061p7229.pdf | 579.28 kB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.